This research finds that an inertial microfluidic platform improves circulating tumor cell isolation in pancreatic cancer, suggesting enhanced early detection capabilities.
An inertial microfluidic platform enables label-free enrichment of rare circulating cells in pancreatic cancer, outperforming immunomagnetic separation and highlighting its translational potential for early detection and disease monitoring.
No takes yet. Share an insight, caveat, or question.
Macaraniag et al. (2025) studied this question.